"Other than out-of-pocket costs, I would wager that prior authorization review is the one thing consumers find most burdensome in our current health system," says Drew Altman, president and CEO of KFF.
Some employers are concerned about how employees will adapt if they revise or eliminate incentive programs. These authors show how behavioral economics precepts can help ease incentive program transitions.
The survey also noted that 34% of firms require lifestyle or clinical support programs in order for employees to receive GLP-1 agonists for weight loss.
Younger generations are especially anxious, with nearly 90% of Gen Z and millennials saying an unplanned medical cost would disrupt their financial plans.
